| EMA number | EMEA/H/C/002488 |
| ATC code | M05BA08 |
| Authorisation | 20 April 2012 |
| Withdrawn | 1 March 2024 |
| Revision | 16 |
Prevention of skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. Treatment of adult patients with tumour-induced hypercalcaemia.